Azithromycin, potential COVID-19 drug, may increase risk for cardiac events | Health News

Washington: A commonly-prescribed antibiotic, Azithromycin, is being investigated as a potential treatment for COVID-19. Azithromycin`s association with cardiac events also has been debated. In 2012, the FDA issued a warning for azithromycin stating that it had been linked to cardiac events, but subsequent studies have yielded mixed results. Now, researchers…

Read More Azithromycin, potential COVID-19 drug, may increase risk for cardiac events | Health News